Serial 99525978
Live / Allowed — Notice of allowance issued (as of 04 Aug 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 02 Dec 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99525978
- Mark type
- Design / logo
- Filed
- 02 Dec 2025
- Published for opposition
- 09 Jun 2026
- Attorney of record
- Malaika D. Tyson
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of cancer and autoimmune disorders and diseases; Therapeutic pharmaceuticals for the treatment of cancer and autoimmune disorders and diseases; Anti-cancer preparations; immunosuppressive pharmaceutical preparations
- Class 042 — Scientific and technological services: Pharmaceutical research and development; Scientific research and development; Research and development in the field of medical preparations, drug discovery, oncology, autoimmunity, and immunology
Owner
- Cullinan Therapeutics, Inc., Cambridge, MA, US
- Cullinan Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 04 Aug 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 09 Jun 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 Jun 2026 — PUBLISHED FOR OPPOSITION
- 03 Jun 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 11 May 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 25 Apr 2026 — ASSIGNED TO EXAMINER
- 24 Apr 2026 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 24 Apr 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 02 Dec 2025 — APPLICATION FILING RECEIPT MAILED
- 02 Dec 2025 — NEW APPLICATION ENTERED